Turtle Cameron sold SYRE
October 1, 2026 · Form 4 insider transaction
Turtle Cameron sold 100 shares of Spyre Therapeutics, Inc. at $93.91 per share, a transaction worth $9.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$93.91
Total value
$9.4K
InsiderTurtle Cameron
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 1, 2026
Filing dateOctober 2, 2026
Shares owned after537,540
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.; Includes 29,078 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.